ANVS Annovis Bio Inc

Price (delayed)

$2.03

Market cap

$70.33M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.71

Enterprise value

$56.11M

?
Relative Growth: Rel. Growth: 5
Relative Strength: Rel. Strength: 9
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 1

Headquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease (AD), Parkinson's disease (PD) and Alzheimer's in Down Syndrome (AD-DS). ...

Highlights
The EPS has declined by 22% since the previous quarter but it has grown by 19% year-on-year
The quick ratio has dropped by 88% year-on-year and by 79% since the previous quarter
ANVS's equity has dropped by 87% year-on-year and by 81% since the previous quarter

Key stats

What are the main financial stats of ANVS

ANVS stock price

How has the Annovis Bio stock price performed over time
Intraday
9.73%
1 week
6.84%
1 month
-10.96%
1 year
-37.35%
YTD
-41.33%
QTD
-8.97%

Financial performance

How have Annovis Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$41.42M
Net income
-$40.92M
Gross margin
N/A
Net margin
N/A
The company's operating income has shrunk by 65% YoY and by 39% QoQ
The net income is down by 42% since the previous quarter and by 41% year-on-year

Price vs fundamentals

How does ANVS's price correlate with its fundamentals

Growth

What is Annovis Bio's growth rate over time

Valuation

What is Annovis Bio stock price valuation
P/E
N/A
P/B
18.41
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 22% since the previous quarter but it has grown by 19% year-on-year
The price to book (P/B) is 150% more than the 5-year quarterly average of 6.7 and 115% more than the last 4 quarters average of 7.8
ANVS's equity has dropped by 87% year-on-year and by 81% since the previous quarter

Efficiency

How efficient is Annovis Bio business performance
The company's return on equity has shrunk by 100% QoQ and by 6% YoY
The return on assets has dropped by 61% since the previous quarter and by 11% year-on-year

Dividends

What is ANVS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANVS.

Financial health

How did Annovis Bio financials performed over time
Annovis Bio's total assets is 24% higher than its total liabilities
ANVS's current ratio has plunged by 88% YoY and by 78% from the previous quarter
The quick ratio has dropped by 88% year-on-year and by 79% since the previous quarter
The company's debt is 100% lower than its equity
ANVS's equity has dropped by 87% year-on-year and by 81% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.